Preclinical Pharmacology and Pharmacokinetics of GW433908, a Water-Soluble Prodrug of the Human Immunodeficiency Virus Protease Inhibitor Amprenavir

Por Furfine, Eric S., Baker, Christopher T., Hale, Michael R., Reynolds, David J., Salisbury, Jo A., Searle, Andy D., Studenberg, Scott D., Todd, Dan, Tung, Roger D., Spaltenstein, Andrew
Publicado em 2004

Design of a superior cytokine antagonist for topical ophthalmic use

Por Hou, Jinzhao, Townson, Sharon A., Kovalchin, Joseph T., Masci, Allyson, Kiner, Olga, Shu, Yanqun, King, Bracken M., Schirmer, Emily, Golden, Kathryn, Thomas, Christoph, Garcia, K. Christopher, Zarbis-Papastoitsis, Gregory, Furfine, Eric S., Barnes, Thomas M.
Publicado em 2013

In Vitro Antiviral Activity of the Novel, Tyrosyl-Based Human Immunodeficiency Virus (HIV) Type 1 Protease Inhibitor Brecanavir (GW640385) in Combination with Other Antiretrovirals...

Por Hazen, Richard, Harvey, Robert, Ferris, Robert, Craig, Charles, Yates, Phillip, Griffin, Philip, Miller, John, Kaldor, Istvan, Ray, John, Samano, Vincente, Furfine, Eric, Spaltenstein, Andrew, Hale, Michael, Tung, Roger, St. Clair, Marty, Hanlon, Mary, Boone, Lawrence
Publicado em 2007

Changes in Human Immunodeficiency Virus Type 1 Gag at Positions L449 and P453 Are Linked to I50V Protease Mutants In Vivo and Cause Reduction of Sensitivity to Amprenavir and Impro...

Por Maguire, Michael F., Guinea, Rosario, Griffin, Philip, Macmanus, Sarah, Elston, Robert C., Wolfram, Josie, Richards, Naomi, Hanlon, Mary H., Porter, David J. T., Wrin, Terri, Parkin, Neil, Tisdale, Margaret, Furfine, Eric, Petropoulos, Chris, Snowden, B. Wendy, Kleim, Jörg-Peter
Publicado em 2002

CT322, a VEGFR-2 antagonist, demonstrates anti-glioma efficacy in orthotopic brain tumor model as a single agent or in combination with temozolomide and radiation therapy

Por Waters, J. Dawn, Sanchez, Carlos, Sahin, Ayguen, Futalan, Diahnn, Gonda, David D., Scheer, Justin K., Akers, Johnny, Palanichamy, Kamalakannan, Waterman, Peter, Chakravarti, Arnab, Weissleder, Ralph, Morse, Brent, Marsh, Nick, Furfine, Eric, Chen, Clark C., Carvajal, Irvith, Carter, Bob S.
Publicado no J Neurooncol (2012)

Anti-tumor effect of CT-322 as an adnectin inhibitor of vascular endothelial growth factor receptor-2

Por Mamluk, Roni, Carvajal, Irvith M, Morse, Brent A, Wong, Henry, Abramowitz, Janette, Aslanian, Sharon, Lim, Ai-Ching, Gokemeijer, Jochem, Storek, Michael J, Lee, Joonsoo, Gosselin, Michael, Wright, Martin C, Camphausen, Ray T, Wang, Jack, Chen, Yan, Miller, Kathy, Sanders, Kerry, Short, Sarah, Sperinde, Jeff, prasad, Gargi, Williams, Stephen, Kerbel, Robert, ebos, John, Mutsaers, Anthony, Mendlein, John D, Harris, Alan S, Furfine, Eric S
Publicado em 2010

A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptor

Por Emanuel, Stuart L, Engle, Linda J, Chao, Ginger, Zhu, Rong-Rong, Cao, Carolyn, Lin, Zheng, Yamniuk, Aaron, Hosbach, Jennifer, Brown, Jennifer, Fitzpatrick, Elizabeth, Gokemeijer, Jochem, Morin, Paul, Morse, Brent, Carvajal, Irvith M, Fabrizio, David, Wright, Martin C, Das Gupta, Ruchira, Gosselin, Michael, Cataldo, Daniel, Ryseck, Rolf P, Doyle, Michael L, Wong, Tai W, Camphausen, Raymond T, Cload, Sharon T, Marsh, H Nicholas, Gottardis, Marco M, Furfine, Eric S
Publicado em 2011